TABLE 1.
Baseline demographic characteristics of the pooled study population
| Characteristic | EDS‐PBO (n = 161) | All EDS‐FLU (n = 482) | Total (N = 643) |
|---|---|---|---|
| Age (years), mean ± SD | 46.0 ± 12.47 | 45.2 ± 12.77 | 45.4 ± 12.69 |
| % Female | 51.6 | 44.2 | 46.0 |
| Race, n (%) | |||
| White | 143 (88.8) | 441 (91.5) | 584 (90.8) |
| Black/African American | 11 (6.8) | 28 (5.8) | 39 (6.1) |
| Asian | 5 (3.1) | 4 (0.8) | 9 (1.4) |
| Other | 2 (1.2) | 9 (1.9) | 11 (1.7) |
| Any surgical history, n (%) | 93 (57.8) | 264 (54.8) | 357 (55.5) |
| Polypectomy | 63 (39.1) | 172 (35.7) | 235 (36.5) |
| FESS | 57 (35.4) | 175 (36.3) | 232 (36.1) |
| SNOT‐22 total score, mean ± SD | 52.9 ± 18.90 | 49.0 ± 19.75 | 49.9 ± 19.60 |
EDS‐FLU = exhalation delivery system with fluticasone; EDS‐PBO = exhalation delivery system with placebo; FESS = functional endoscopic sinus surgery; SD = standard deviation; SNOT‐22 = Sino‐Nasal Outcome Test.